Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000239227 encodes a pseudogene with sequence similarity to part of S-phase kinase-associated protein 2 (SKP2), also known as P45 SKP2[1]. Pseudogenes are segments of DNA similar to known genes but lacking the ability to encode a functional protein. This gene does not produce a functional receptor, enzyme, transporter, nor is it a valid therapeutic target. It may be referenced in gene catalogs due to its homology to the SKP2 locus, but should not be confused with the actual *SKP2* gene, which encodes a substrate recognition component of an E3 ubiquitin ligase and is involved in cell cycle regulation, cancer, and other diseases[2][5]. No drug interactions, disease mechanisms, or clinical utility are associated with ENSG00000239227.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of S-phase kinase-associated protein 2 (ENSG00000239227).